IGFBP2 Human shRNA Plasmid Kit (Locus ID 3485)
CAT#: TR316590
IGFBP2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
IGFBP2 mouse monoclonal antibody, clone OTI1A7 (formerly 1A7)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | IGFBP2 Human shRNA Plasmid Kit (Locus ID 3485) |
Locus ID | 3485 |
UniProt ID | P18065 |
Synonyms | IBP2; IGF-BP53 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | IGFBP2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 3485). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_000597, NM_001313990, NM_001313992, NM_001313993, NM_000597.1, NM_000597.2, BC004312, BC004312.1, BC009902, BC012769, BC071967 |
Summary | The protein encoded by this gene is one of six similar proteins that bind insulin-like growth factors I and II (IGF-I and IGF-II). The encoded protein can be secreted into the bloodstream, where it binds IGF-I and IGF-II with high affinity, or it can remain intracellular, interacting with many different ligands. High expression levels of this protein promote the growth of several types of tumors and may be predictive of the chances of recovery of the patient. Several transcript variants, one encoding a secreted isoform and the others encoding nonsecreted isoforms, have been found for this gene. [provided by RefSeq, Sep 2015] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Novel anti IGFBP2 single chain variable fragment inhibits glioma cell migration and invasion.
,null,
Journal of neuro-oncology
,PubMed ID 25944386
[IGFBP2]
|
Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with ?-catenin in breast cancer lymph node metastasis
,null,
Molecular Cancer
,PubMed ID 23767917
[IGFBP2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...